Concord Medical Services Stock Performance

CCM Stock  USD 3.97  0.07  1.79%   
The firm shows a Beta (market volatility) of 2.15, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Concord Medical will likely underperform. At this point, Concord Medical Services has a negative expected return of -0.36%. Please make sure to confirm Concord Medical's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Concord Medical Services performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Concord Medical Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more

Actual Historical Performance (%)

One Day Return
2.31
Five Day Return
(5.23)
Year To Date Return
(6.56)
Ten Year Return
(91.86)
All Time Return
(95.22)
Last Split Factor
1:10
Dividend Date
2016-01-29
Ex Dividend Date
2015-12-23
Last Split Date
2024-07-30
1
Wayfinder Family Services Achieves Highest Possible Accreditation Scores
01/21/2026
2
In HelloNation, Autism Expert Veronica Glickman of Autism Behavioral and Educational Services, Inc. Discusses Going Beyond the Therapy Room
01/26/2026
3
Cinch Home Services Champions Local Education to Support Literacy and Skilled Trades in Palm Beach and Broward Counties
01/28/2026
4
The Braff Group Advises Childs Play Therapy Services in its Partnership with Proficio Therapy Services
01/29/2026
5
Local Small Business Owner Opens Pak Mail Inside of His Existing Accounting Business in Springville, Alabama--Offering Shipping and Office Services
01/30/2026
6
Da de la Marmota Phil predice 6 semanas ms de clima invernal en EEUU
02/02/2026
7
Looking At The Apple AAPL Narrative After Gemini Deal And Margin Concerns
02/03/2026
Begin Period Cash Flow90.4 M
Total Cashflows From Investing Activities-593.4 M

Concord Medical Relative Risk vs. Return Landscape

If you would invest  557.00  in Concord Medical Services on November 6, 2025 and sell it today you would lose (160.00) from holding Concord Medical Services or give up 28.73% of portfolio value over 90 days. Concord Medical Services is generating negative expected returns assuming volatility of 6.2928% on return distribution over 90 days investment horizon. In other words, 56% of stocks are less volatile than Concord, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Concord Medical is expected to under-perform the market. In addition to that, the company is 8.42 times more volatile than its market benchmark. It trades about -0.06 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Concord Medical Target Price Odds to finish over Current Price

The tendency of Concord Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.97 90 days 3.97 
about 78.04
Based on a normal probability distribution, the odds of Concord Medical to move above the current price in 90 days from now is about 78.04 (This Concord Medical Services probability density function shows the probability of Concord Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.15 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Concord Medical will likely underperform. Additionally Concord Medical Services has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Concord Medical Price Density   
       Price  

Predictive Modules for Concord Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Concord Medical Services. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Concord Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.204.0210.31
Details
Intrinsic
Valuation
LowRealHigh
0.183.599.88
Details
Naive
Forecast
LowNextHigh
0.073.479.76
Details

Concord Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Concord Medical is not an exception. The market had few large corrections towards the Concord Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Concord Medical Services, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Concord Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.43
β
Beta against Dow Jones2.15
σ
Overall volatility
0.53
Ir
Information ratio -0.06

Concord Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Concord Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Concord Medical Services can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Concord Medical generated a negative expected return over the last 90 days
Concord Medical has high historical volatility and very poor performance
Concord Medical has high likelihood to experience some financial distress in the next 2 years
Concord Medical Services has 3.93 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable Concord to fund expansion initiatives and generate superior returns.
The entity reported the last year's revenue of 383.96 M. Reported Net Loss for the year was (652.08 M) with loss before taxes, overhead, and interest of (41.85 M).
Concord Medical Services has about 157.39 M in cash with (397.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Concord Medical has a poor financial position based on the latest SEC disclosures
Roughly 18.0% of Concord Medical shares are held by company insiders
Latest headline from finance.yahoo.com: Looking At The Apple AAPL Narrative After Gemini Deal And Margin Concerns

Concord Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Concord Stock often depends not only on the future outlook of the current and potential Concord Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Concord Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding145.6 K
Cash And Short Term Investments350.8 M

Concord Medical Fundamentals Growth

Concord Stock prices reflect investors' perceptions of the future prospects and financial health of Concord Medical, and Concord Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Concord Stock performance.

About Concord Medical Performance

By examining Concord Medical's fundamental ratios, stakeholders can obtain critical insights into Concord Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Concord Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 30.31  28.79 
Return On Tangible Assets(0.06)(0.07)
Return On Capital Employed(0.12)(0.13)
Return On Assets(0.05)(0.06)
Return On Equity 0.12  0.14 

Things to note about Concord Medical Services performance evaluation

Checking the ongoing alerts about Concord Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Concord Medical Services help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Concord Medical generated a negative expected return over the last 90 days
Concord Medical has high historical volatility and very poor performance
Concord Medical has high likelihood to experience some financial distress in the next 2 years
Concord Medical Services has 3.93 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. That said, strategic use of leverage may enable Concord to fund expansion initiatives and generate superior returns.
The entity reported the last year's revenue of 383.96 M. Reported Net Loss for the year was (652.08 M) with loss before taxes, overhead, and interest of (41.85 M).
Concord Medical Services has about 157.39 M in cash with (397.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Concord Medical has a poor financial position based on the latest SEC disclosures
Roughly 18.0% of Concord Medical shares are held by company insiders
Latest headline from finance.yahoo.com: Looking At The Apple AAPL Narrative After Gemini Deal And Margin Concerns
Evaluating Concord Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Concord Medical's stock performance include:
  • Analyzing Concord Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Concord Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Concord Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Concord Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Concord Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Concord Medical's stock. These opinions can provide insight into Concord Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Concord Medical's stock performance is not an exact science, and many factors can impact Concord Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.40)
Revenue Per Share
83.728
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.04)
Return On Equity
(0.29)
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.